We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

964 hedge funds and large institutions have $48B invested in Thermo Fisher Scientific in 2015 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 336 increasing their positions, 398 reducing their positions, and 67 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more call options, than puts

Call options by funds: $260M | Put options by funds: $149M

24% more first-time investments, than exits

New positions opened: 83 | Existing positions closed: 67

12% more funds holding in top 10

Funds holding in top 10: 6775 (+8)

5% more capital invested

Capital invested by funds: $45.5B → $48B (+$2.45B)

0% more funds holding

Funds holding: 960964 (+4)

0.79% less ownership

Funds ownership: 90.96%90.17% (-0.79%)

16% less repeat investments, than reductions

Existing positions increased: 336 | Existing positions reduced: 398

Holders
964
Holders Change
+4
Holders Change %
+0.42%
% of All Funds
25.69%
Holding in Top 10
75
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+11.94%
% of All Funds
2%
New
83
Increased
336
Reduced
398
Closed
67
Calls
$260M
Puts
$149M
Net Calls
+$112M
Net Calls Change
+$59.7M
Name Holding Trade Value Shares
Change
Change in
Stake
AG
226
Aperio Group
California
$16.8M +$1.79M +13,918 +13%
AR
227
Advisory Research
Illinois
$16.6M +$15.9M +123,442 New
FQ
228
First Quadrant
California
$16.5M
GP
229
GLG Partners
United Kingdom
$16.5M -$2.04M -15,810 -11%
CCM
230
Channing Capital Management
Illinois
$16.4M -$2.26M -17,493 -13%
GHA
231
GW Henssler & Associates
Georgia
$16.4M -$1.44M -11,183 -8%
BPCE
232
Bank Pictet & Cie (Europe)
Germany
$16.2M +$5.56M +43,115 +55%
CHA
233
Cedar Hill Associates
Illinois
$16.2M +$207K +1,609 +1%
TAM
234
Tocqueville Asset Management
New York
$16.1M +$8.39M +65,059 +119%
NIMI
235
Natixis Investment Managers International
France
$16.1M -$808K -6,267 -5%
Robeco Institutional Asset Management
236
Robeco Institutional Asset Management
Netherlands
$15.7M -$528K -4,092 -3%
TCT
237
TIAA CREF Trust
Missouri
$15.7M -$489K -3,796 -3%
GIBU
238
Gulf International Bank (UK)
United Kingdom
$15.5M +$32K +248 +0.2%
CC
239
Cornerstone Capital
California
$15.2M -$180K -1,400 -1%
GF
240
Gabelli Funds
New York
$15.2M +$4.25M +33,000 +41%
GT
241
Glenmede Trust
Pennsylvania
$15M +$4.22M +32,714 +41%
RCM
242
Riverhead Capital Management
Delaware
$15M -$7.83M -60,752 -35%
DMIC
243
Dixon Mitchell Investment Counsel
British Columbia, Canada
$14.6M -$60.3K -468 -0.4%
SLAM
244
Swiss Life Asset Management
$14.5M +$13.9M +107,777 New
ECM
245
Endurant Capital Management
California
$14M -$2.15M -16,700 -14%
CCMH
246
Cornerstone Capital Management Holdings
New York
$14M +$11.5K +89 +0.1%
SCM
247
Suffolk Capital Management
New York
$13.8M
WG
248
Winton Group
United Kingdom
$13.8M -$8.97M -69,582 -40%
AC
249
Addenda Capital
Quebec, Canada
$13.7M -$184K -1,427 -1%
HCM
250
Howland Capital Management
Massachusetts
$13.6M -$172K -1,336 -1%

TMO Hedge Fund Activity: Q1 2015 in Review

964 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2015, worth a combined $48B — up 5.4% from $45.5B a quarter earlier.

Buyers outnumbered sellers: 83 funds opened new TMO positions and 67 closed out — a net gain of 16 holders — while 336 added to existing stakes and 398 trimmed.

The largest buyer was Capital World Investors, adding an estimated $324M. The largest seller was Glenview Capital Management, cutting an estimated $577M.

  • 964 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2015, up from 960 in Q4 2014.
  • Funds reported $48B of Thermo Fisher Scientific stock for Q1 2015, up 5.4% quarter-over-quarter.
  • 83 funds opened new Thermo Fisher Scientific positions in Q1 2015 and 67 closed out, a net change of +16 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2015 was Capital World Investors, an estimated $324M added.
  • The largest Thermo Fisher Scientific seller in Q1 2015 was Glenview Capital Management, an estimated $577M sold.

Based on aggregated 13F filings for Q1 2015.